Caitlyn Krebs

• Understanding the development of synthetic cannabinoids through advanced AI platforms and in silico modelling to design novel synthetic compounds
• Illustrating how these compounds bind to CB1 and CB2 receptors and how their activity can be biased
• A case study to explore the connection between the endocannabinoid system and endometriosis, emphasizing cannabinoid intervention as a promising yet under-researched therapeutic approach

NEW DATA

• Explore effective strategies to engage and educate patients, clinicians, and advocacy groups to drive awareness and increase participation in cannabinoid clinical trials for endometriosis.
• Identify the key regulatory, societal, and commercial barriers limiting patient access to cannabinoid-based therapies and evaluating solutions
• Examine how industry collaboration, policy evolution, and patient advocacy can work together to accelerate the responsible adoption of cannabinoid treatments in women’s health